Keratosis Pilaris Treatment Market
Number of pages: 100 | Report Format: PDF | Published date: February 20, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
CAGR |
4.26% |
|
Base Year For Estimation |
2021 |
|
Forecast Period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Treatment Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, and the Rest of the World (RoW) |
According to the deep-dive market assessment study by Growth Plus Reports, the global keratosis pilaris treatment market is expected to register a revenue CAGR of 4.26% during the forecast period.
Keratosis Pilaris Treatment Market Fundamentals
Keratosis pilaris, or chicken skin, is the most prevalent and non-contagious skin condition. The disorder results in tiny, painful lumps, which damage the texture of the skin. The bumps frequently have a pale complexion. They commonly occur on the upper arms, thighs, and buttocks, and may be accompanied by redness or swelling. Keratosis pilaris is caused by the accumulation of keratin, a protein that defends the skin from infections and other hazardous substances. The buildup creates a block that prevents hair follicles.
Even though keratosis pilaris is a frequent condition, its specific cause is still unknown. The disorder is inherited in an autosomal dominant manner. Filaggrin mutations have been linked to keratosis pilaris and abnormalities in the RAS signaling cascade. Mutations in the filaggrin gene may cause follicular abnormalities. This link, along with mutations in the filaggrin gene, shows that keratosis pilaris is caused by a lack of normal epithelial barrier function. Moreover, recent studies have suggested a link between vitamin A deficiency and keratosis pilaris. Additionally, people with asthma, hypothyroidism, diabetes, and obesity are also prevalent to develop the disease due to hormonal imbalance. This disease is very common in the adolescent age group. When teenagers come into their late adolescence, the bumps can disappear. Hormonal imbalance, on the other hand, can trigger another flare-up around puberty. Keratosis pilaris usually clears by the mid-20s if it begins during adolescence.
Keratosis Pilaris Treatment Market Dynamics
The increasing prevalence of keratosis pilaris is the key factor driving the global keratosis treatment market. This condition is more prone in children and young adults due to changes in hormones. According to the 2021 estimates of the British Association of Dermatologists, about 50% of people have keratosis pilaris. About 40% of adults and 50% to 70% of teenagers are affected by it.
Advancements in treatment for keratosis pilaris are another factor driving revenue growth in the global keratosis treatment market. For instance, chlorine dioxide is a powerful antibacterial and anti-inflammatory agent that is non-toxic to humans. This is highly used in keratosis pilaris, which inactivates the intracellular defense system, with no side effects. Chlorine dioxide is an excellent cleaning agent. Furthermore, it acts as a keratolytic agent by neutralizing reactive oxygen molecules and breaking the intramolecular and intermolecular disulfide bonds that hold keratin together.
Social hesitation among adults plays a significant role in increasing the revenue growth of the keratosis pilaris treatment market. Many people with keratosis pilaris feel self-conscious about the appearance of their skin, especially in social situations. As more people seek solutions to manage the condition, the market for keratosis pilaris treatment is likely to grow during the forecast period.
Keratosis Pilaris Treatment Market Ecosystem
The global keratosis pilaris treatment market has been analyzed from three perspectives: treatment type, end user, and region.
Keratosis Pilaris Treatment Market by Treatment Type
[4534234]
Based on treatment type, the global keratosis pilaris treatment market is segmented into topical exfoliants, topical retinoids, and others.
The topical exfoliants segment leads the global ketosis pilaris treatment market in terms of revenue. The topical exfoliants segment is further sub-segmented into lotions, creams, and others. Topical exfoliants have significant advantages in treating keratosis pilaris. Exfoliants are essential in removing small keratin lumps covering follicles. Moreover, topical exfoliants focus on removing dead skin and reducing hair follicles. Moreover, topical exfoliants are advantageous since keratosis pilaris typically goes away in the 30s. Lotions containing alpha hydroxy acid, lactic acid, salicylic acid, and urea aid in removing dead skin cells and are primary exfoliants prescribed by the doctor. Topical retinoids are creams that are derived from vitamin A, and they function by accelerating cell renewal and avoiding clogged hair follicles. Topical retinoids include medications, such as tazarotene (Arazlo, Avage, Tazorac, and others) and tretinoin (Avita, Renova, Retin-A, and others), which improves the texture of the skin. The exfoliating properties of vitamin A derivative also promote the growth of new skin cells, resulting in the smoothing of chicken skin bumps.
Several laser treatments, including 532nm potassium-titanyl-phosphate (KTP) laser, 595nm pulsed-dye laser (PDL), long-pulsed 1,064nm neodymium-doped yttrium aluminum garnet (Nd: YAG) laser, Q-switched 1,064nm Nd: YAG laser, 810nm diode laser, and fractional carbon dioxide laser are effective in treating keratosis pilaris. Moreover, the treatment can certainly reduce rough skin texture and uneven skin tone.
Keratosis Pilaris Treatment Market by End User
Based on the end user, the global keratosis pilaris treatment market is segmented into hospitals, dermatology clinics, home care settings, and others.
The hospitals segment dominates the global keratosis pilaris treatment market due to their access to more specialized equipment and personnel than other care providers. Hospitals provide better treatment for keratosis pilaris. Additionally, they offer access to more advanced specialists, including dermatologists and plastic surgeons, who can treat the condition with greater efficacy. Hospitals have a greater ability to monitor and track progress, ensuring that patients receive the best possible care. Furthermore, hospitals have access to more advanced treatment options, such as laser treatment.
Keratosis Pilaris Treatment Market by Region
Regionally, the global keratosis pilaris treatment market has been segmented into North America, Europe, Asia Pacific, and the rest of the world.
North America dominated the market with the highest revenue share in 2021 due to an increase in awareness of keratosis pilaris, a high rate of treatment adoption owing to an increase in physician prescriptions, and developments in laser therapy in the U.S. During the projection period, the segment is expected to be driven by favorable regulatory policies, an increase in the number of keratosis pilaris sales made through online pharmacies, and a rise in the amount of private players’ spending for R&D activities.
The market in Asia Pacific is likely to grow at high revenue CAGR during the forecast period. Some of the major factors propelling the global keratosis pilaris treatment market throughout the projection period include an increase in treatment adoption, improved disposable income of consumers, and high disease prevalence in some countries, such as India, Australia, and New Zealand.
Keratosis Pilaris Treatment Market Competitive Landscape
The prominent players operating in the global keratosis pilaris treatment market are:
Keratosis Pilaris Treatment Market Strategic Developments
The global keratosis pilaris treatment market is driven by increasing awareness about actinic keratosis, knowledge about diagnostics and treatment strategies, and various strategic initiatives undertaken by industry players.
Neostrata Company, Inc., Procter & Gamble Company, SLMD Skincare, Johnson & Johnson Pvt. Ltd., Galderma S.A., and Touch Skin Care are among the top market players.
Complications after keratosis treatment can hamper the global keratosis pilaris treatment market revenue growth to some extent.
The global keratosis pilaris treatment market is expected to witness a CAGR of 4.26 % during the forecast period from 2022 to 2030.
The topical exfoliants segment accounted for the majority of the revenue share in 2021.
*Insights on financial performance are subject to the availability of information in the public domain